STK11 and lung cancer: Inactivating mutations of the bona fide TSG STK11 (i.e., LKB1; serine/threonine kinase 11) are common in lung cancer, modulate differentiation and metastasis in vivo, and have been observed more frequently patients with smoking history (29–31).